Skip to content

Clinical trials

Observational Coronary Artery Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Observational Country / region: Netherlands Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20072
20083
20092
20102
20113
20126
20132
20147
20153
20165
20174
20186
20195
20206
20214
20224
20233
20242
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Unknown status15
Recruiting14
Withdrawn2
Terminated2
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Erasmus Medical Center6
Maastricht University Medical Center6
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)5
Abbott Medical Devices4
Catharina Ziekenhuis Eindhoven4
Radboud University Medical Center4
Amsterdam UMC, location VUmc3
UMC Utrecht3
Volcano Corporation3
Cathreine BV2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease81
Atherosclerosis11
Myocardial Infarction10
Acute Coronary Syndrome9
Coronary Stenosis9
Myocardial Ischemia7
Cardiovascular Diseases5
Angina Pectoris3
Angina, Unstable3
Aortic Valve Disease3

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.